Ranokhon Igamberdieva

Работ: 30

Tashkent pediatric medical institute, Internal medicine, Tashkent, Uzbekistan

1. P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS

   Sherzod Abdullaev, Ranokhon Igamberdieva

   СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.article.002654

2. Epidemiological, clinical and morphological aspects of kidney damage in COVID-19

   Batir Daminov, Sherzod Abdullaev, Olimkhon Sharapov +1

   СтатьяCOVID-19 Clinical Research StudiesJournal of Renal Injury Prevention2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.001967

3. MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.002955

4. POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION

   Ranokhon Igamberdieva, Sherzod Abdullaev, Olimkhon Sharapov

   СтатьяNeurological Disorders and TreatmentsKidney International Reports2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.004689

5. MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

   Sherzod Abdullaev, Ranokhon Igamberdieva, Olimkhon Sharapov

   СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.006221

6. MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF

   Ranokhon Igamberdieva, Sherzod Abdullaev

   СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.002165

7. POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF

   Ranokhon Igamberdieva, Sherzod Abdullaev

   СтатьяAtrial Fibrillation Management and OutcomesKidney International Reports2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.002924

8. POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD

   Sherzod Abdullaev, Ranokhon Igamberdieva

   СтатьяAtrial Fibrillation Management and OutcomesKidney International Reports2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.002970

9. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

   Sherzod Abdullaev, Ranokhon Igamberdieva

   СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.004913

10. MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.004975

11. MO143: Dynamics of Renal Function during Anticoagulant Therapy in Stage 4 CKD and AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.004978

12. Oral anticoagulation in end-stage CKD and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяAtrial Fibrillation Management and OutcomesInternational Journal of Health Sciences2022Цитирований: 0

    ABIABI:AkademIndex/openalex/2022.article.007035

13. #3055 ASSOCIATION OF MORTALITY WITH INTRADIALYTIC EXERCISE IN HEMODIALYSIS PATIENTS

    Sherzod Abdullaev, Ranokhon Igamberdieva

    СтатьяDialysis and Renal Disease ManagementNephrology Dialysis Transplantation2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.002567

14. #3896 SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.003120

15. #2765 EVALUATION OF ANTIBODY RESPONSES TO SARS-COV-2 VACCINES IN PATIENTS WITH CKD

    Sherzod Abdullaev, Olimkhon Sharapov, Ranokhon Igamberdieva

    СтатьяSARS-CoV-2 and COVID-19 ResearchNephrology Dialysis Transplantation2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.008409

16. #3897 STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF THE HEART IN ELDERLY AND OLD PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяHealthcare Systems and Public HealthNephrology Dialysis Transplantation2023Цитирований: 0

    ABIABI:AkademIndex/openalex/2023.article.008418

17. #1912 Assessment of the dynamics of renal anemia in patients with atrial fibrillation and chronic kidney disease stage IIIb-V during anticoagulant therapy

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяHealthcare Systems and Public HealthNephrology Dialysis Transplantation2024Цитирований: 0

    ABIABI:AkademIndex/openalex/2024.article.003483

18. #2562 Effect of rituximab on post-transplant outcome in highly sensitized patients

    Sherzod Abdullaev, Ranokhon Igamberdieva

    СтатьяRenal Transplantation Outcomes and TreatmentsNephrology Dialysis Transplantation2024Цитирований: 0

    ABIABI:AkademIndex/openalex/2024.article.006258

19. #1986 Incidence of renal anemia among patients with atrial fibrillation and chronic kidney disease stage IIIb-V

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2024Цитирований: 0

    ABIABI:AkademIndex/openalex/2024.article.006263

20. #1994 Analysis of dynamics of parameters of safety and effectiveness of rivaroxaban in patients with stage IV chronic kidney disease and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2024Цитирований: 0

    ABIABI:AkademIndex/openalex/2024.article.006267

21. #377 Assessment of kidney function by creatinine and cystatin C and cardiovascular outcomes in patients with atrial fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    СтатьяBlood Pressure and Hypertension StudiesNephrology Dialysis Transplantation2024Цитирований: 0

    ABIABI:AkademIndex/openalex/2024.article.006281

22. #206 The effect of dapagliflozin on anemia in patients with CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    СтатьяDiabetes Treatment and ManagementNephrology Dialysis Transplantation2024Цитирований: 0

    ABIABI:AkademIndex/openalex/2024.article.006290

23. WCN25-3811 PROGRESSION OF ANTICOAGULANT-RELATED NEPHROPATHY AFTER ANTICOAGULANT THERAPY

    Sherzod Abdullaev, Ranokhon Igamberdieva

    СтатьяAmyloidosis: Diagnosis, Treatment, OutcomesKidney International Reports2025Цитирований: 0

    ABIABI:AkademIndex/openalex/2025.article.003425

24. #1825 Monitoring of atrial indicators in patients with chronic kidney disease and atrial fibrillation after radio-frequency ablation

    Ranokhon Igamberdieva, Sherzod Abdullaev, Музаффар Илхомжон Асомов

    СтатьяAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation2025Цитирований: 0

    ABIABI:AkademIndex/openalex/2025.article.009272

25. #2598 Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease

    Rakhimjon Tursunbayev, Sherzod Abdullaev, Музаффар Илхомжон Асомов +1

    СтатьяLiver Disease Diagnosis and TreatmentNephrology Dialysis Transplantation2025Цитирований: 0

    ABIABI:AkademIndex/openalex/2025.article.009281